Factors influencing results include: Starting weight Metabolic health Medication adherence Protein intake Exercise habits Medical history Our goal is not rapid weight loss but sustainable weight management and improved overall health
Maintaining basal-bolus GLP-1 levels as a treatment approach These studies have clearly shown that MBS corrects post-prandial GLP-1 responses in people with obesity but does not improve fasting GLP-1 levels, which remain lower in some patients as compared to normal-weight individuals
Prescriptions for semaglutide and tirzepatide among patients with PCOS Between 2021 and 2025, 445,258 patients with PCOS had at least one medical encounter, of whom 90,206 (20.3%) received a semaglutide or tirzepatide prescription during the study period
The blend is administered as a single subcutaneous injection once daily, typically before bed to align with natural GH secretion patterns
A., Millanvoye-Van Brussel, E